Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results

TScan Therapeutics, Inc. (TCRX) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/24/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/24/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
06/15/2023 4 BARBERICH TIMOTHY J (Director) has filed a Form 4 on TScan Therapeutics, Inc.
Txns: Granted 35,000 options to buy @ $2.66, valued at $93.1k
06/15/2023 4 Barton Debora (Chief Medical Officer) has filed a Form 4 on TScan Therapeutics, Inc.
Txns: Granted 430,000 options to buy @ $2.49, valued at $1.1M
06/15/2023 4 Dorton Katina (Director) has filed a Form 4 on TScan Therapeutics, Inc.
Txns: Granted 35,000 options to buy @ $2.66, valued at $93.1k
06/15/2023 4 Gruia Gabriela (Director) has filed a Form 4 on TScan Therapeutics, Inc.
Txns: Granted 35,000 options to buy @ $2.66, valued at $93.1k
06/15/2023 4 Klencke Barbara (Director) has filed a Form 4 on TScan Therapeutics, Inc.
Txns: Granted 36,524 options to buy @ $2.66, valued at $97.2k
06/15/2023 4 Silver Brian M. (CFO) has filed a Form 4 on TScan Therapeutics, Inc.
Txns: Granted 632,500 options to buy @ $2.49, valued at $1.6M
06/15/2023 4 MacBeath Gavin (CEO) has filed a Form 4 on TScan Therapeutics, Inc.
Txns: Granted 1,121,300 options to buy @ $2.49, valued at $2.8M
06/15/2023 4 ZDRAVESKI ZORAN (Chief Legal Officer) has filed a Form 4 on TScan Therapeutics, Inc.
Txns: Granted 430,000 options to buy @ $2.49, valued at $1.1M
06/06/2023 4 BARBERICH TIMOTHY J (Director) has filed a Form 4 on TScan Therapeutics, Inc.
Txns: Bought 37,880 shares @ $2.6284, valued at $99.6k
06/02/2023 4 Lynx1 Capital Management LP (10% Owner) has filed a Form 4 on TScan Therapeutics, Inc.
Txns: Sold 10,000 shares @ $2.5148, valued at $25.1k
Sold 15,000 shares @ $2.5201, valued at $37.8k
Sold 400 shares @ $2.5075, valued at $1k
06/02/2023 3 Lynx1 Capital Management LP (10% Owner) has filed a Form 3 on TScan Therapeutics, Inc.
02/06/2023 4 SOUTHWELL DAVID P (CEO) has filed a Form 4 on TScan Therapeutics, Inc.
Txns: Granted 100,000 options to buy @ $1.81, valued at $181k
02/06/2023 4 MacBeath Gavin (See Remarks) has filed a Form 4 on TScan Therapeutics, Inc.
Txns: Granted 40,000 options to buy @ $1.81, valued at $72.4k
02/06/2023 4 ZDRAVESKI ZORAN (Chief Legal Officer) has filed a Form 4 on TScan Therapeutics, Inc.
Txns: Granted 35,000 options to buy @ $1.81, valued at $63.4k
02/06/2023 4 Barton Debora (Chief Medical Officer) has filed a Form 4 on TScan Therapeutics, Inc.
Txns: Granted 50,000 options to buy @ $1.81, valued at $90.5k
12/29/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/27/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/27/2022 4 Desmarais William (Chief Business Officer) has filed a Form 4 on TScan Therapeutics, Inc.
Txns: Granted 30,000 options to buy @ $3.27, valued at $98.1k
07/27/2022 4 Silver Brian M. (CFO) has filed a Form 4 on TScan Therapeutics, Inc.
Txns: Granted 220,000 options to buy @ $3.27, valued at $719.4k
07/27/2022 4 ZDRAVESKI ZORAN (Chief Legal Officer) has filed a Form 4 on TScan Therapeutics, Inc.
Txns: Granted 50,000 options to buy @ $3.27, valued at $163.5k
07/27/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/07/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/07/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
06/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/03/2022 4 Gruia Gabriela (Director) has filed a Form 4 on TScan Therapeutics, Inc.
Txns: Granted 9,146 options to buy @ $3.17, valued at $29k
06/03/2022 4 Harel Ittai (Director) has filed a Form 4 on TScan Therapeutics, Inc.
Txns: Granted 9,146 options to buy @ $3.17, valued at $29k
05/20/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/12/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/28/2022 4 Silver Brian M. (CFO) has filed a Form 4 on TScan Therapeutics, Inc.
Txns: Bought 15,000 shares @ $3.3988, valued at $51k
01/20/2022 4 Desmarais William (Chief Business Officer) has filed a Form 4 on TScan Therapeutics, Inc.
Txns: Granted 50,000 options to buy @ $4.85, valued at $242.5k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy